Clinical players and healthcare payers: aligning perspectives on the cost-effectiveness of next-generation sequencing in oncology
- PMID: 29767540
- DOI: 10.2217/pme.14.81
Clinical players and healthcare payers: aligning perspectives on the cost-effectiveness of next-generation sequencing in oncology
Keywords: cancer; clinical tumor sequencing; cost–effectiveness analysis; economic evaluation; reimbursement; value assessment; whole-genome sequencing.
LinkOut - more resources
Full Text Sources